Copyright ©ERS Journals Ltd 2009 Clinical course and lung function change of idiopathic nonspecific interstitial pneumonia1 Division of Pulmonary and Critical Care Medicine, 2 Dept of Radiology, 3 Dept of Rheumatology, and 4 Dept of Pathology, University of Ulsan, College of Medicine, Asan Medical Center, Seoul, Korea, 5 Laboratory and Anatomic Pathology, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan, 6 Dept of Histopathology, Royal Brompton Hospital, London, UK, and 7 Dept of Laboratory Medicine and Pathology, Mayo Clinic, Scottsdale, AZ, USA, 8 These authors contributed equally to the study as first authors. CORRESPONDENCE: D. S. Kim, Division of Pulmonary and Critical Care Medicine, University of Ulsan College of Medicine, Asan Medical Center, 388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, Korea. Fax: 82 230106968. E-mail: dskim{at}amc.seoul.kr Keywords: Clinical course, fibrotic nonspecific interstitial pneumonia, pulmonary function test, recurrence
Received: November 23, 2007
Most studies of idiopathic nonspecific interstitial pneumonia (NSIP) have primarily studied mortality. In order to clarify the detailed outcome and prognostic markers in idiopathic NSIP, the clinical course with initial radiological and clinical features was analysed.
The clinical course of 83 patients who were classified with idiopathic NSIP (72 fibrotic, 11 cellular; 27 males and 56 females; mean±SD age 54.4±10.1 yrs) was retrospectively analysed.
In fibrotic NSIP, 16 (22%) patients died of NSIP-related causes with a median (range) follow-up of 53 (0.3–181) months. Despite the favourable survival (5-yr 74%), patients with fibrotic NSIP were frequently hospitalised with recurrence rate of 36%. Reduced forced vital capacity at 12 months was a predictor of mortality. On follow-up, lung function was improved or stable in
In conclusion, the overall prognosis of fibrotic nonspecific interstitial pneumonia was good; however, there were significant recurrences despite initial improvement and a subset of the patients did not respond to therapy. Some patients developed collagen vascular diseases at a later date.
| |||||||||||||||||||||||